Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Wave Life Sciences (WVE) Non-Current Receivables (2018 - 2020)

Wave Life Sciences (WVE) has disclosed Non-Current Receivables for 3 consecutive years, with $30.0 million as the latest value for Q1 2020.

  • For the quarter ending Q1 2020, Non-Current Receivables fell 40.0% year-over-year to $30.0 million, compared with a TTM value of $30.0 million through Mar 2020, down 40.0%, and an annual FY2019 reading of $30.0 million, down 40.0% over the prior year.
  • Non-Current Receivables was $30.0 million for Q1 2020 at Wave Life Sciences, roughly flat from $30.0 million in the prior quarter.
  • Across five years, Non-Current Receivables topped out at $50.0 million in Q2 2018 and bottomed at $30.0 million in Q2 2019.
  • Average Non-Current Receivables over 3 years is $40.0 million, with a median of $40.0 million recorded in 2018.
  • Peak annual rise in Non-Current Receivables hit 40.0% in 2019, while the deepest fall reached 40.0% in 2019.
  • Year by year, Non-Current Receivables stood at $50.0 million in 2018, then tumbled by 40.0% to $30.0 million in 2019, then changed by 0.0% to $30.0 million in 2020.
  • Business Quant data shows Non-Current Receivables for WVE at $30.0 million in Q1 2020, $30.0 million in Q4 2019, and $30.0 million in Q3 2019.